SCYX Scynexis Inc

SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  05/02/2014
Outstanding shares:  32,579,491
Average volume:  101,032
Market cap:   $60,597,853
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.73
PB ratio:   1.40
PS ratio:   33.67
Return on equity:   -86.42%
Net income %:   -1,868.94%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy